Ligand validation:3NHX

ASD: 4-ANDROSTENE-3-17-DIONE

ASD is a Ligand Of Interest in 3NHX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NHX_ASD_A_126	1%	9%	0.635	0.704	1.83	2.8	7	13	2	0	100%	0.5
3NUV_ASD_B_126	52%	18%	0.121	0.879	1.59	2.09	4	11	4	0	100%	0.9524
3NBR_ASD_A_129	4%	17%	0.266	0.627	1.83	1.96	4	9	0	0	100%	0.5
4QDC_ASD_A_404	85%	33%	0.101	0.965	1.06	1.67	1	9	0	0	100%	1
4JBT_ASD_B_502	83%	42%	0.083	0.942	0.8	1.48	-	6	0	0	100%	1
8JBZ_ASD_AAA_602	81%	59%	0.104	0.958	0.56	0.98	-	2	5	0	100%	1
4QCK_ASD_A_404	81%	46%	0.124	0.978	0.83	1.27	1	4	0	0	100%	1
4AT2_ASD_A_1490	65%	45%	0.111	0.914	0.78	1.36	-	4	0	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.